laboratory managed by Serge Goblet
| | | | | |

Serge Goblet: The Visionary Empire of 159 Million Euros, from Commerce to Revolutionary Biotechnology

Updated on

Serge Goblet

Serge Goblet is a significant investor with a substantial net assets, valued at €159,388,000. Its main areas of activity are holding and real estate (Tolefi), with a strong presence in Brussels. Its empire rests on three main pillars: wholesale and distribution, real estate investments and investments in biotechnology companies. These include, Celyad Oncology SA is at the top of the list.

Celayd logo managed by Serge Goblet

Celyad Oncologylocated in Mont-Saint-Guibert, Belgium, is a company specialized biotechnology in innovative chimeric antigen receptor T cell (CAR T) therapies for cancer treatment. This company, listed on Euronext and NASDAQ focuses on revolutionary therapies for cancer patients.

Serge Goblet's real estate company

Goblet's investments in Celyad Oncology are part of an advanced biotechnology research framework. Celyad has obtained FDA approval for a study of its cardiac regeneration treatment, C-Cure, for patients suffering from chronic heart disease. This stem cell-based therapy represents a major breakthrough and began clinical trials in Europe in 2013, with the first treatments carried out in June 2014.

charcoal sold by Serge Goblet

Goblet's portfolio is also highly diverse, including assets in Belgium and abroad, such as the distribution of mobile heating products, charcoal and pallets in Francein Italy and Spain. In conclusion, its commitment to biotechnology, and in particular to companies such as Celyad, underlines its crucial role in medical advances and the development of new products. contemporary therapeutics. This enabled him to accumulate a fortune of over 150 million euros.

Similar Posts

  • Moortgat family: Belgian brewery's ascent to a fortune of 1.8 billion euros

    Since its foundation in 1871, the Moortgat family brewery has evolved from a modest brewery farm into one of Belgium's most successful and innovative breweries. The acquisition of the Maredsous brewery in 1963 and the management of Tuborg's bottling rights for the Benelux countries marked the first steps in its expansion.

  • Dr. Paul Janssen: The Visionary Entrepreneur Behind a 300 Million Euro Fortune and a Pharmaceutical Legacy

    Dr. Paul Janssen, founder of Janssen Pharmaceutica, is one of the most influential figures in the Belgian pharmaceutical industry. With a legacy estimated at over 300 million euros, Janssen revolutionized medicine with innovative medicines, while remaining a central figure in the company after its takeover by Johnson & Johnson. In addition to his medical contributions, he left a significant cultural imprint, with a unique collection of pre-Columbian art. Discover how this visionary built a pharmaceutical empire while influencing Belgian art and economics.

  • Frank Bamelis and Bart Vanderschrick: The 41-Million-Euro Titanic Empire in Senior Care

    Frank Bamelis and Bart Vanderschrick, founders of Senior Assist in 2006, have built an empire in the elderly care sector, valued at over 41 million euros. Their company manages 32 residential care centers and 147 assisted living facilities in Belgium, accommodating nearly 2,800 residents and employing 1,800 people. Despite international expansion and service diversification, Senior Assist encountered financial difficulties in 2017, leading to the sale of certain assets. The company, structured with a plurality of shareholders and present in Luxembourg, illustrates the challenges and opportunities of the senior care sector, which is constantly evolving to meet the needs of an aging population.

  • The Rousseaux Family and Christophe Rousseaux: From Immoweb to Innovation with 221 Million Euros

    Christophe Rousseaux, a key figure in the Rousseaux family, has built a fortune of over 221 million euros through Immoweb, Belgium's largest real estate platform. Heirs to the family empire, Christophe and Tanguy Rousseaux have diversified their investments through the Akiles fund, consolidating their wealth. The Rousseaux family's influence in both real estate and start-ups continues to make its mark on the Belgian and European economies.